Related Experiment Videos
MYC amplification in squamous cell carcinomas of the head and neck
J P Rodrigo1, P S Lazo, S Ramos
1Otorhinolaryngology Service, Hospital Central de Asturias, Oviedo, Spain.
Objectives:
To establish the frequency of MYC amplification in squamous cell carcinoma (SCC) of the head and neck to evaluate its correlation with clinicopathologic variables that are used in clinical practice.
Design:
Cohort analytic study.
Setting:
University Hospital.
Patients:
Fifty-nine consecutive patients with SCC of the head and neck.
Intervention:
Oncologic surgery.
Main Outcome Measures:
The MYC copy number in tumor samples was estimated with the polymerase chain reaction. The presence or absence of amplification was correlated with the anatomic site, T stage, nodal involvement, pathologic grade, recurrence, distant metastases, and survival.
Results:
Six SCC specimens (11%) showed MYC amplification. A highly statistical correlation between MYC amplification and T stage was noted (P < .005). Amplification was also significantly correlated with a hypopharyngeal primary site (P < .05). No correlation among amplification status, nodal involvement, pathologic grade, relapse, metastases, and survival was observed.
Conclusions:
Amplification of MYC is associated with advanced primary tumors, and it appears to be a late event in the tumorigenesis of SCCS of the head and neck. However, there is no correlation between MYC amplification and prognosis.